{"url_path":"/sec/traw/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-061779-index.html","accession_number":"0001104659-26-061779","cik":"0001130598","ticker":"TRAW","issuer_name":"Traws Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-061779-index.html","primary_entity_key":"0001130598","primary_entity_name":"Traws Pharma, Inc."},"word_count":278,"has_tables":true,"body_markdown":"**Item 6. Exhibits**\n\n**EXHIBIT INDEX**\n\n**Exhibit********Number**\n\n  ​ ​ ​\n\n**Description**\n\n31.1\n\n *\n\n[Rule 13a-14(a)/15d-14(a) Certifications of Principal Executive Officer](traw-20260331xex31d1.htm)\n\n31.2\n\n *\n\n[Rule 13a-14(a)/15d-14(a) Certifications of Principal Financial Officer](traw-20260331xex31d2.htm)\n\n32.1\n\n **\n\n[Section 1350 Certifications of Principal Executive Officer](traw-20260331xex32d1.htm)\n\n32.2\n\n **\n\n[Section 1350 Certifications of Principal Financial Officer](traw-20260331xex32d2.htm)\n\n101.INS\n\n†\n\nInline XBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document\n\n101.SCH\n\n† \n\nInline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents\n\n104\n\n†\n\nCover Page Interactive Data File -The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document\n\n​\n\n*   Filed herewith\n\n** Furnished herewith\n\n† The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.\n\n​\n\n​\n\n35\n\n[Table of Contents](#TOC)\n\n**SIGNATURES**\n\n​\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n​\n\n \n\n**TRAWS PHARMA, INC.**\n\n \n\n \n\nDated: May 15, 2026\n\n \n\n \n\n \n\n \n\n*/s/ Iain Dukes, D. Phil*\n\n \n\nIain Dukes, D. Phil\n\n \n\nChief Executive Officer\n\n \n\n(*Duly Authorized Officer and Principal Executive Officer*)\n\n \n\n \n\nDated: May 15, 2026\n\n \n\n \n\n \n\n \n\n*/s/ Charles Parker*\n\n \n\nCharles Parker\n\n \n\nChief Financial Officer\n\n \n\n(*Principal Financial Officer and Principal Accounting Officer*)\n\n​\n\n​\n\n36"}